Patents Assigned to The University of Sydney Centenary Institute of Cancer Medicine and Cell Biology
  • Prevention and treatment of mycobacterium infection
    Patent number: 9610337
    Abstract: The invention relates to the identification of antigens, including Mycobacterium sulphate assimilation pathway components such as CysD, for preventing and treating Mycobacterium infection, especially but not exclusively Mycobacterium tuberculosis infection; to expression systems including live Mycobacterium for expression of said antigens for prevention and treatment of said infection; and to use of said antigens and expression systems for prevention and treatment of said infection.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: April 4, 2017
    Assignee: The University of Sydney Centenary Institute of Cancer Medicine and Cell Biology
    Inventors: James Anthony Triccas, Rachel Pinto-Nadanachandran, Warwick John Britton